Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis
Year: 2009
Type: article
Study design: Clinical Trial
Source: Leukemia Research
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Topic: Mast cells and histamine
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
Funder: National Cancer Institute
Award: Cancer Center Support Grant
OpenAlex ID: W2126677578
